AKAN (AKAN) Stock Price & Analysis
AKAN (AKAN) fell 4.21% to USD 7.73 as of July 25, 2026 at 04:21 UTC, according to Nexqual real-time market data.
AKAN last closed at USD 8.07; the session ranged USD 7.11–14 on volume of 5,700,057 shares. Market capitalization is $4.18M, with a 52-week range of USD 2.3–209.23 (NCM). Source: Nexqual, July 25, 2026 at 04:21 UTC.
Key Statistics (as of July 25, 2026 at 04:21 UTC)
| Price | USD 7.73 |
|---|---|
| Change | ▼ 4.21% (down) |
| Previous Close | USD 8.07 |
| Open | USD 10 |
| Day Range | USD 7.11 – 14 |
| 52-Week Range | USD 2.3 – 209.23 |
| Volume | 5,700,057 shares |
| Market Cap | $4.18M |
| Exchange | NCM |
Technical Analysis (AKAN)
Nexqual's technical model rates AKAN "SELL" based on 2 bullish and 5 bearish signals across 125 daily candles, as of July 25, 2026 at 04:21 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 27.58 (oversold) |
| vs SMA50 | Below (USD 15.17) |
| MACD | -2.13 (negative) |
Analyst Ratings (AKAN)
Wall Street analysts rate AKAN "None", per Nexqual as of July 25, 2026 at 04:21 UTC.
| Consensus Rating | None |
|---|
Earnings (AKAN)
Source: Nexqual, July 25, 2026 at 04:21 UTC.
Financials & Fundamentals (AKAN)
| Total Revenue | $258,075 |
|---|---|
| Gross Margin | -60.46% |
| Operating Margin | -1353.34% |
| Profit Margin | +0.00% |
| Current Ratio | 0.58 |
| Total Cash | $503,562 |
| Total Debt | $14.24M |
| Free Cash Flow | $-5.71M |
Source: Nexqual, July 25, 2026 at 04:21 UTC.
Financial Health Score (AKAN)
Nexqual rates AKAN's overall financial health "Weak" across five dimensions, as of July 25, 2026 at 04:21 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Critical — Heavily loss-making — early-stage company |
| Balance Sheet | Mixed — $504K cash vs $14M debt |
| Cash Flow | Weak — FCF negative: -$6M, burning cash |
| Efficiency | Mixed — No data |
Ownership (AKAN)
| Insider Ownership | +0.59% |
|---|---|
| Institutional Ownership | +1.21% |
| Shares Outstanding | 540,841 |
| Float | 537,663 |
| Short % of Float | +3.38% |
Source: Nexqual, July 25, 2026 at 04:21 UTC.
Leadership (AKAN)
AKAN is led by Katharyn Field (age 42), Interim CEO & Executive Director, per Nexqual as of July 25, 2026 at 04:21 UTC.
| Interim CEO & Executive Director | Katharyn Field (age 42) |
|---|---|
| Chief Financial Officer | Gurcharn Deol B.A., M.A. (age 57) |
| VP, COO & Director of First Towers | Francisco Juarez (age 46) |
Major Backers & Investors (AKAN)
Notable institutional backers of AKAN include HRT Financial LP, Xtx Topco Ltd, according to Nexqual as of July 25, 2026 at 04:21 UTC.
Active Investors
| Investor | Stake |
|---|---|
| HRT Financial LP | 0.64% |
| Xtx Topco Ltd | 0.47% |
Source: Nexqual, July 25, 2026 at 04:21 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| VRAX | Virax Biolabs Group Limited | USD 3.19 | ▼ 12.36% |
| LUCY | Innovative Eyewear, Inc. | USD 0.65 | ▼ 4.43% |
| GWAV | Greenwave Technology Solutions, | USD 2.63 | ▼ 9% |
| SOBR | SOBR Safe, Inc. | USD 0.6 | ▲ 3.01% |
| SPRC | SciSparc Ltd. | USD 5.33 | ▲ 10.12% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 04:21 UTC. This page is informational and not investment advice.